RxDoctor Payments Data

Amrish Patel

Allergy & Immunology · Royal Oak, MINPI 1952326225

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AstraZeneca at 33.6% of the total.

$4,071in general payments, 2019–2025

Across 178 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$476
  • Novartis$469
  • Genentech USA, Inc.$396
  • Takeda Pharmaceuticals U.S.A., Inc.$225
  • Sunovion Pharmaceuticals Inc.$205
  • plus $932 from 18 others

What the payments were for

  • Consulting fees$231%
  • Food & beverage$4,04899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,071 in reported general payments places this provider in the 60th percentile of 119 allergy & immunology providers in Michigan.

See all allergy & immunology providers in Michigan

Other allergy & immunology in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →